Shares of American Well Corporation (NYSE:AMWL - Get Free Report) rose 0.2% during mid-day trading on Friday . The stock traded as high as $7.06 and last traded at $6.99. Approximately 31,050 shares traded hands during trading, a decline of 50% from the average daily volume of 61,942 shares. The stock had previously closed at $6.97.
Wall Street Analyst Weigh In
AMWL has been the subject of several research analyst reports. Wells Fargo & Company dropped their price target on American Well from $15.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Piper Sandler reaffirmed a "neutral" rating and set a $8.00 price target (down previously from $10.00) on shares of American Well in a research note on Friday, May 23rd. Finally, UBS Group lowered their target price on American Well from $12.00 to $9.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. One investment analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat.com, American Well currently has a consensus rating of "Hold" and an average price target of $9.17.
Get Our Latest Research Report on American Well
American Well Stock Performance
The business has a 50-day simple moving average of $7.76 and a 200 day simple moving average of $7.76. The firm has a market cap of $108.04 million, a P/E ratio of -0.83 and a beta of 1.27.
American Well (NYSE:AMWL - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported ($1.24) EPS for the quarter, beating analysts' consensus estimates of ($1.84) by $0.60. The business had revenue of $70.90 million during the quarter, compared to analyst estimates of $63.87 million. American Well had a negative return on equity of 41.99% and a negative net margin of 46.15%. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts expect that American Well Corporation will post -9.34 EPS for the current year.
Insider Buying and Selling
In other American Well news, Director Deborah C. Jackson sold 4,531 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $7.10, for a total transaction of $32,170.10. Following the completion of the transaction, the director owned 48,194 shares of the company's stock, valued at $342,177.40. This represents a 8.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Phyllis Gotlib sold 4,958 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $8.63, for a total value of $42,787.54. Following the transaction, the insider directly owned 136,891 shares of the company's stock, valued at $1,181,369.33. The trade was a 3.50% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 9,820 shares of company stock valued at $77,814 in the last ninety days. 12.80% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Headlands Technologies LLC purchased a new position in shares of American Well during the 2nd quarter worth approximately $39,000. Sapient Capital LLC purchased a new position in shares of American Well during the 1st quarter worth approximately $79,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of American Well during the 2nd quarter worth approximately $89,000. OMERS ADMINISTRATION Corp purchased a new position in shares of American Well during the 4th quarter worth approximately $76,000. Finally, Engineers Gate Manager LP purchased a new position in shares of American Well during the 2nd quarter worth approximately $101,000. Hedge funds and other institutional investors own 56.05% of the company's stock.
About American Well
(
Get Free Report)
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
See Also
Before you consider American Well, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Well wasn't on the list.
While American Well currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.